TRIM family contribute to tumorigenesis, cancer development, and drug resistance

37Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The tripartite-motif (TRIM) family represents one of the largest classes of putative single protein RING-finger E3 ubiquitin ligases. TRIM family is involved in a variety of cellular signaling transductions and biological processes. TRIM family also contributes to cancer initiation, progress, and therapy resistance, exhibiting oncogenic and tumor-suppressive functions in different human cancer types. Moreover, TRIM family members have great potential to serve as biomarkers for cancer diagnosis and prognosis. In this review, we focus on the specific mechanisms of the participation of TRIM family members in tumorigenesis, and cancer development including interacting with dysregulated signaling pathways such as JAK/STAT, PI3K/AKT, TGF-β, NF-κB, Wnt/β-catenin, and p53 hub. In addition, many studies have demonstrated that the TRIM family are related to tumor resistance; modulate the epithelial–mesenchymal transition (EMT) process, and guarantee the acquisition of cancer stem cells (CSCs) phenotype. In the end, we havediscussed the potential of TRIM family members for cancer therapeutic targets.

Cite

CITATION STYLE

APA

Huang, N., Sun, X., Li, P., liu, X., Zhang, X., Chen, Q., & Xin, H. (2022, December 1). TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Experimental Hematology and Oncology. BioMed Central Ltd. https://doi.org/10.1186/s40164-022-00322-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free